ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Passes Above 50 Day Moving Average – Time to Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $20.32 and traded as high as $22.20. ChronoScale Corporation Common Stock shares last traded at $20.26, with a volume of 233,404 shares traded.

ChronoScale Corporation Common Stock Trading Down 8.5%

The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $65.93 million, a price-to-earnings ratio of -3.44 and a beta of 0.99. The business has a 50-day moving average of $20.42 and a two-hundred day moving average of $14.09.

Get ChronoScale Corporation Common Stock alerts:

ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) last posted its quarterly earnings results on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. The firm had revenue of $18.09 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. Research analysts predict that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

Several large investors have recently modified their holdings of CHRN. Roble Belko & Company Inc grew its position in ChronoScale Corporation Common Stock by 104.5% in the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after acquiring an additional 1,195 shares during the period. Geode Capital Management LLC increased its holdings in shares of ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after purchasing an additional 10,281 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter valued at $57,000. Shay Capital LLC acquired a new position in shares of ChronoScale Corporation Common Stock during the third quarter valued at $67,000. Finally, Citadel Advisors LLC acquired a new position in shares of ChronoScale Corporation Common Stock during the third quarter valued at $198,000. 6.42% of the stock is currently owned by institutional investors.

About ChronoScale Corporation Common Stock

(Get Free Report)

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.

Recommended Stories

• Five stocks we like better than ChronoScale Corporation Common Stock
• Why SK hynix Could Be the Best AI Chip Stock to Buy Now
• Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
• Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
• Why Bloom Energy May Be the Most Important AI Infrastructure Stock

Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.